Share Email Print
cover

Proceedings Paper • new

Potassium selenocyanate potentiate antimicrobial photodynamic inactivation (Conference Presentation)
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

We previously showed that antimicrobial photodynamic inactivation (aPDI) of Gram-positive and Gram-negative bacteria mediated by the phenothiazinium dye, methylene blue (MB) was potentiated by addition of potassium thiocyanate (10mM). The mechanism was suggested to involve a singlet oxygen mediated reaction with SCN- to form sulfite and cyanide and then to produce sulfur trioxide radical anion. We now report that potassium selenocyanate (KSeCN) (concentrations up to 100 mM) can also potentiate (up to 6 logs of killing) aPDI mediated by a number of different photosensitizers: MB, Rose Bengal, and TPPS4 (as low as 200 nM). When a mixture of selenocyanate with these PS in solution was illuminated and then bacteria were added after the light, there was up to 6 logs killing (Gram-negative > Gram-positive) but the antibacterial species decayed rapidly (by 20 min). Our hypothesis to explain this antibacterial activity is the formation of selenocyanogen (SeCN)2 by reaction with singlet oxygen (1O2) as shown by quenching of 1O2 by SeCN- and increased photoconsumption of oxygen. The fact that lead tetra-acetate reacted with SeCN- (literature preparation of (SeCN)2) also produced a short-lived antibacterial species supports this hypothesis.

Paper Details

Date Published: 4 March 2019
PDF
Proc. SPIE 10863, Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases II, 108630S (4 March 2019); doi: 10.1117/12.2506706
Show Author Affiliations
Liyi Huang, Guangxi Medical Univ. (China)
Michael Hamblin, Wellman Ctr. for Photomedicine (United States)


Published in SPIE Proceedings Vol. 10863:
Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases II
Tianhong Dai; Jürgen Popp; Mei X. Wu M.D., Editor(s)

© SPIE. Terms of Use
Back to Top